The Indiana Horse Racing Commission (IHRC) April 30 adopted the Controlled Therapeutic Medication Schedule and multiple medication violation penalty system. But a regulatory watchdog organization said it's premature to call it uniformity because the rules aren't in lockstep with the National Uniform Medication Program.

The IHRC unanimously approved model rule threshold levels for 24 commonly used therapeutic drugs. However, earlier in April, the Association of Racing Commissioners International (RCI) added albuterol—said to be an alternative to the bronchodilator clenbuterol—and isoflupredone (a corticosteroid that can be used to treat allergic, musculoskeletal, and inflammatory ailments) to the list. Indiana plans to add them at a later date.

The testing thresholds for the 24 original drugs on the schedule will take effect May 15 at Indiana Grand Race Course (which opens May 6) and Hoosier Park Racing & Casino (which began its harness racing meet in late March).

"We applaud the state of Indiana and the Indiana Horse Racing Commission for joining the growing number of states that have adopted these important reforms in their entirety," said Alex Waldrop, president and chief executive officer of the National Thoroughbred Racing Association and chairman of the Racing Medication and Testing Consortium (RMTC). "Along with the recent RMTC accreditation of three national testing laboratories, this represents another important step toward our goal of national adoption and implementation of uniform rules, penalties, and testing standards

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.